HOME >> BIOLOGY >> NEWS
Protein identified that regulates effectiveness of Taxol chemotherapy in breast cancer

Washington, DC -- Cancer researchers at Georgetown University Medical Center have taken a step towards understanding how and why a widely used chemotherapy drug works in patients with breast cancer.

In laboratory studies, the researchers isolated a protein, caveolin-1, showing that in breast cancer cells this protein can enhance cell death in response to the use of Taxol, one of two taxane chemotherapy drugs used to treat advanced breast and ovarian cancer. But in order to work, they found the protein needs to be "switched on," or phosphorylated. The results were reported in the current (February 23) issue of the Journal of Biological Chemistry.

Their finding suggests it may eventually be possible to test individual breast cancer patients for the status of such molecular markers as caveolin-1 in their tumors to determine the efficacy-to-toxicity ratio for Taxol, said the studys first author, postdoctoral fellow Ayesha Shajahan, Ph.D., of Lombardi Comprehensive Cancer Center at Georgetown.

"Because breast tumors are not all the same, it is important to know the cancers molecular makeup in order to increase the efficiency, and lower the toxicity, of chemotherapy drugs, and this work takes us some steps forward in this goal," she said. "It also offers insights into why some breast cancer cells can become resistant to therapeutic drugs."

Additionally, the study identifies caveolin-1 as a new molecular target for increasing the efficacy of taxanes, according to the studys lead investigator, Robert Clarke, Ph.D., D.Sc., a Professor of Oncology and Physiology & Biophysics. "This is important because the taxanes are active drugs in breast cancer, so now that we know caveolin-1 is a new mechanism to explain how these drugs kill breast cancer cells, we can potentially take advantage of that fact to improve these agents."

The taxanes are Taxol (also known as paclitaxel) and Taxotere (docetaxel). Taxol was originally deriv
'"/>

Contact: Laura Cavender
lsc6@georgetown.edu
202-687-5100
Georgetown University Medical Center
21-Feb-2007


Page: 1 2 3

Related biology news :

1. Protein chatter linked to cancer activation
2. Coming soon -- Protein synthesis without amino acids?
3. Protein pulling -- Learning how proteins fold by pulling them apart
4. Protein interactions targets for Huntington disease therapy
5. Protein enables discovery of quantum effect in photosynthesis
6. Protein found that slows hepatitis C growth in liver cells
7. Protein fragments sequenced in 68 million-year-old Tyrannosaurus rex
8. Protein averts cell suicide but might contribute to cancer
9. Protein structures for the entire yeast proteome
10. Protein overexpression at heart of heart failure
11. Protein sciences

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2019)... ... 2019 , ... RoosterBio, Inc, a leading supplier of innovative ... Annual Meeting & Exposition on April 3-6, 2019 in Seattle, Washington. , ... business professionals in all aspects of the biomaterial science field who are advancing ...
(Date:3/27/2019)... ... March 27, 2019 , ... ... been awarded the 2019 Global Health & Pharma Biotechnology Award as the Best ... & Pharma’s Biotechnology Awards honor individuals and companies whose accomplishments have proved evidence ...
(Date:3/25/2019)... ... March 25, 2019 , ... Ambry Genetics , a ... today announced a new laboratory services agreement with Clovis Oncology Inc., a biopharmaceutical ... this laboratory services agreement, Ambry Genetics and Clovis Oncology seek to identify clinical ...
Breaking Biology News(10 mins):
(Date:4/10/2019)... ... April 10, 2019 , ... After more than three ... The new kitchen is equipped with updated appliances and modern lighting and fixtures, and ... venue. , “We’ve seen tremendous growth in the demand for our team-building ...
(Date:4/9/2019)... , ... April 09, 2019 , ... Sonny Bar Lisa, ... front limb for approximately two months. After a series of diagnostics, an MRI ... Sonny’s owner, Alison, researched the injury and found that VetStem Regenerative Cell ...
(Date:4/8/2019)... ... April 08, 2019 , ... CallTower, ... today the launch of their app integration solution, CT Cloud Unite. CT ... applications while using CT Cloud Voice and Skype for Business solutions. This robust ...
(Date:4/8/2019)... ... April 09, 2019 , ... ... innovative non-profit research center Chan Zuckerberg Biohub (CZ Biohub) has chosen Geneious Biologics ... repertoires is part of CZ Biohub’s efforts to establish new approaches to inform ...
Breaking Biology Technology:
Cached News: